Gtree Pharmaceuticals
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Nd Florida 248, Dalga, Queensland, 46...Website
www.gtreepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Gtree Pharmaceuticals
Gtree Pharmaceuticals is a biopharmaceutical company established in June 2014, focusing on the development of innovative drugs for ophthalmic and rare diseases. The company is currently conducting clinical trials for its lead product, GBT-201, aimed at treating dry eye syndrome and neurotrophic keratitis. Gtree Pharmaceuticals targets both domestic and international markets, particularly in South Korea and the United States. Their commitment to research and development positions them as a key player in the biopharmaceutical industry.Explore more
Popular SearchesGtree Pharmaceuticals Co LtdSIC Code 28,283NAICS Code 32,325Show more
Gtree Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gtree Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Gtree Pharmaceuticals had a recent Job posting/layoffs
Check if Gtree Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gtree Pharmaceuticals
Check out if Gtree Pharmaceuticals is spiking on competitors!
Gtree Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Gtree Pharmaceuticals has new funding data
Earning: See what the market has to say on Gtree Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Gtree Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Gtree Pharmaceuticals
Compare insights from companies similar to Gtree Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gtree Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gtree Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gtree Pharmaceuticals.
Gtree Pharmaceuticals Tech Stack
A closer look at the technologies used by Gtree Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Gtree Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Gtree Pharmaceuticals is a biopharmaceutical company established in June 2014, focusing on the development of innovative drugs for ophthalmic and rare diseases. The company is currently conducting clinical trials for its lead product, GBT-201, aimed at treating dry eye syndrome and neurotrophic keratitis. Gtree Pharmaceuticals targets both domestic... Read More
